A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination with Dexamethasone in T-ALL/T-LBL Patients
Phase of Trial: Phase I/II
Latest Information Update: 17 Jul 2018
At a glance
- Drugs Crenigacestat (Primary) ; Dexamethasone (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eli Lilly
- 09 Jul 2018 Status changed from active, no longer recruiting to completed.
- 19 Apr 2018 This study has been completed in Germany (End date: 2018-01-15).
- 18 Apr 2018 This study has been completed in Sweden (End date: 2018-01-15).